As of 2024-09-17, the Relative Valuation of Biogen Inc (BIIB) is 304.29 USD. This relative valuation is based on P/E multiples. With the latest stock price at 199.58 USD, the upside of Biogen Inc based on Relative Valuation is 52.5%.
The range of the Relative Valuation is 261.85 - 459.91 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.9x - 50.1x | 36.4x |
| Forward P/E multiples | 36.8x - 58.4x | 40.5x |
| Fair Price | 261.85 - 459.91 | 304.29 |
| Upside | 31.2% - 130.4% | 52.5% |
| Date | P/E |
| 2024-09-17 | 25.32 |
| 2024-09-16 | 25.09 |
| 2024-09-13 | 24.59 |
| 2024-09-12 | 24.88 |
| 2024-09-11 | 25.03 |
| 2024-09-10 | 25.22 |
| 2024-09-09 | 25.05 |
| 2024-09-06 | 25.25 |
| 2024-09-05 | 25.37 |
| 2024-09-04 | 25.77 |
| 2024-09-03 | 25.75 |
| 2024-08-30 | 25.74 |
| 2024-08-29 | 25.75 |
| 2024-08-28 | 25.67 |
| 2024-08-27 | 25.56 |
| 2024-08-26 | 25.76 |
| 2024-08-23 | 25.77 |
| 2024-08-22 | 25.56 |
| 2024-08-21 | 25.92 |
| 2024-08-20 | 25.83 |
| 2024-08-19 | 25.91 |
| 2024-08-16 | 25.38 |
| 2024-08-15 | 25.35 |
| 2024-08-14 | 25.22 |
| 2024-08-13 | 25.65 |
| 2024-08-12 | 25.27 |
| 2024-08-09 | 25.40 |
| 2024-08-08 | 25.66 |
| 2024-08-07 | 25.12 |
| 2024-08-06 | 25.16 |
| 2024-08-05 | 24.94 |
| 2024-08-02 | 25.86 |
| 2024-08-01 | 26.49 |
| 2024-07-31 | 26.80 |
| 2024-07-30 | 26.64 |
| 2024-07-29 | 26.96 |
| 2024-07-26 | 26.55 |
| 2024-07-25 | 28.59 |
| 2024-07-24 | 28.42 |
| 2024-07-23 | 28.20 |
| 2024-07-22 | 28.49 |
| 2024-07-19 | 28.46 |
| 2024-07-18 | 28.32 |
| 2024-07-17 | 28.71 |
| 2024-07-16 | 28.29 |
| 2024-07-15 | 27.86 |
| 2024-07-12 | 28.92 |
| 2024-07-11 | 29.77 |
| 2024-07-10 | 29.26 |
| 2024-07-09 | 28.80 |